MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.
MyoPax's investors include BioInnovation Institute, EIC Accelerator.
MyoPax is headquartered in Berlin, Germany.
MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.
MyoPax is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MyoPax — Funding & Investors." VCBacked, February 17, 2025, https://www.vcbacked.co/company/myopax. Accessed July 20, 2026.
VCBacked. (2025). MyoPax — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/myopax
{{cite web |title=MyoPax — Funding & Investors |url=https://www.vcbacked.co/company/myopax |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated